| Literature DB >> 20623305 |
Lisette van der Molen1, Maya A van Rossum, Lori M Burkhead, Ludi E Smeele, Coen R N Rasch, Frans J M Hilgers.
Abstract
The aim of this study was to assess the effect of (preventive) rehabilitation on swallowing and mouth opening after concomitant chemoradiotherapy (CCRT). Forty-nine patients with advanced oral cavity, oropharynx, hypopharynx and larynx, or nasopharynx cancer treated with CCRT were randomized into a standard (S) or an experimental (E) preventive rehabilitation arm. Structured multidimensional assessment (i.e., videofluoroscopy, mouth-opening measurement, structured questionnaires) was performed before and 10 weeks after CCRT. In both S and E arms, feasibility was good (all patients could execute the exercises within a week) and compliance was satisfactory (mean days practiced per week was 4). Nevertheless, mouth opening, oral intake, and weight decreased significantly. Compared to similar CCRT studies at our institute, however, fewer patients were still tube-dependent after CCRT. Furthermore, some functional outcomes seemed less affected than those of studies in the literature that did not incorporate rehabilitation exercises. Patients in the E arm practiced significantly fewer days in total and per week, but they obtained results comparable to the S arm patients. Preventive rehabilitation (regardless of the approach, i.e., experimental or standard) in head and neck cancer patients, despite advanced stage and burdensome treatment, is feasible, and compared with historical controls, it seems helpful in reducing the extent and/or severity of various functional short-term effects of CCRT.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20623305 PMCID: PMC3098976 DOI: 10.1007/s00455-010-9288-y
Source DB: PubMed Journal: Dysphagia ISSN: 0179-051X Impact factor: 3.438
Inclusion and exclusion criteria for the randomized controlled clinical trial
| Inclusion | Exclusion |
|---|---|
| Squamous cell carcinoma | Unable to comprehend the function and use of the rehabilitation exercises and device (e.g., Alzheimer’s disease, Korsakov’s disease) |
| Oral cavity, oropharynx, hypopharynx, larynx, and nasopharynx tumors | Physically unfit to use a rehabilitation device (e.g., neurological deficit) |
| Stage III–IV | |
| Primary treatment with CCRT with curative intent | |
| Written informed consent |
Fig. 1CONSORT flow diagram of patient randomization and analysis [25]
Demographics, tumor, and exercise characteristics of the 10-weeks post-treatment patient group (N = 49)
| Characteristics | Post-treatment (10 weeks) [ | Total | |
|---|---|---|---|
| Standard group | Experimental group | ||
| No. of patients | 25 (51) | 24 (49) | 49 |
| Age (years) | |||
| Mean | 57 | 56 | 57 |
| Range | 32–75 | 37–78 | 32–78 |
| Sex | |||
| Male | 16 | 23 | 39 (80) |
| Female | 9 | 1 | 10 (20) |
| T Classification | |||
| T1 | 5 (20) | 3 (13) | 8 (16) |
| T2 | 8 (32) | 7 (29) | 15 (31) |
| T3 | 8 (32) | 11 (46) | 19 (39) |
| T4 | 4 (16) | 3 (13) | 7 (14) |
| N Classification | |||
| N0 | 1 (4) | 3 (13) | 4 (8) |
| N1 | 9 (36) | 5 (21) | 14 (29) |
| N2 | 13 (52) | 13 (53) | 26 (53) |
| N3 | 2 (8) | 3 (13) | 5 (10) |
| Stage | |||
| III | 9 (36) | 7 (29) | 16 (33) |
| IV | 16 (64) | 17 (71) | 33 (67) |
| Tumor site | |||
| Oral cavity/oropharynx | 12 (47) | 12 (50) | 24 (49) |
| Floor of mouth | |||
| Tongue | 2 (8) | 2 (4) | |
| Retromolar trigone | 1 (4) | 1 (2) | |
| Base of tongue | 4 (16) | 6 (25) | 10 (20) |
| Tonsil | 3 (12) | 3 (13) | 6 (12) |
| Soft palate | 1 (4) | 1 (2) | |
| Pharynx posterior wall | 3 (13) | 3 (6) | |
| Valleculae | 1 (4) | 1 (2) | |
| Laryngo/hypopharynx | 9 (37) | 9 (37) | 18 (37) |
| Pyriform sinus | 8 (32) | 8 (33) | 16 (33) |
| Hypopharynx posterior wall | 1 (4) | 1 (2) | |
| Supraglottic larynx | 1 (4) | 1 (2) | |
| Nasopharynx | 4 (16) | 3 (13) | 7 (14) |
Percent of occurrence or mean of functional problems before and 10 weeks after chemoradiotherapy (N = 49)
| Functional outcome | Pretreatment [ | Post-treatment [ |
| ||||||
|---|---|---|---|---|---|---|---|---|---|
| PAS | 0.37 | ||||||||
| Laryngeal penetration | 7 (14%) | 3 (6%) | |||||||
| Laryngeal aspiration | 2 (4%) | 9 (18%) | |||||||
| Score mean (SD) (all consistencies) | 0.95 (0.36) | 1.15 (0.36) | |||||||
| Presence of residue | |||||||||
| None | Above vall | Below vall | Above/below vall | None | Above vall | Below vall | Above/below vall | 0.21 | |
| 1 cc liquid | 13 (26%) | 18 (37%) | 7 (14%) | 11 (22%) | 8 (16%) | 34 (69%) | 2 (4%) | 5 (10%) |
|
| 5 cc liquid | 2 (4%) | 3 (6%) | 1 (2%) | 42 (86%) | 1 (2%) | 25 (51%) | / (0%) | 20 (41%) |
|
| 3 cc paste | 4 (8%) | 16 (33%) | 4 (8%) | 20 (41%) | 5 (10%) | 31 (63%) | / (0%) | 13 (27%) |
|
| Cookie | 6 (12%) | 22 (45%) | 2 (4%) | 16 (33%) | 10 (20%) | 27 (55%) | / (0%) | 8 (16%) | |
| MIO (mm) |
| ||||||||
| Median | 51 | 49 | |||||||
| Mean (SD) | 50 (9.97) | 47 (11.53) | |||||||
| Mean reduction 3 | |||||||||
| Occurrence of trismus (MIO ≤35) | 5 (10%) | 7 (14%) | 0.70 | ||||||
| Weight (kg) | |||||||||
| Median | 76.2 | 71.0 |
| ||||||
| Mean (SD) | 78.1 (16.4) (range = 50.0–108.0) | 72.0 (14.6) | |||||||
| Mean reduction 6.1 kg (7.8%) (range = 43.0–100.0) | |||||||||
| BMI (kg) | 0.25 | ||||||||
| Median | 25.4 | 23.5 | |||||||
| Mean (SD) | 25.1 (5.1) | 23.0 (4.7) | |||||||
| FOIS |
| ||||||||
| Median | 7 | 6 | |||||||
| Mean (SD) | 7 (1) | 5 (2) | |||||||
| Score 1,2,3 intake <50% | 2 (4%) | 17 (35%) | |||||||
| Score 4,5,6,7 intake >50% | 47 (96%) | 32 (65%) | |||||||
| Tube dependencya | 2 (4%) | 18 (37%) |
| ||||||
| Pain score | 0.42 | ||||||||
| No pain (score 1) | 23 (47%) | 22 (45%) | |||||||
| Mild pain (score 2) | 19 (39%) | 24 (49%) | |||||||
| Moderate pain (score 3) | 6 (12%) | 3 (6%) | |||||||
| Severe pain (score 4) | 1 (2%) | / (0%) | |||||||
| Study-specific questionnaire | Mean (SD) | Mean (SD) | |||||||
| Swallowing (7 items) | 9 (2) | 10 (3) | 0.08 | ||||||
| Mouth opening (1 item)b | 1,12 (0.39) | 1,33 (0.67) |
| ||||||
| Information (3 items) | 11 (1) | 11 (1) | 0.29 | ||||||
PAS penetration and aspiration scale, BMI body mass index, MIO maximum interincisor mouth opening, FOIS functional oral intake scale
aAt the end of treatment 38/49 patients (76%) were tube dependent
bA higher score means more problems with opening the mouth
* p ≤ 0.05
Overview of the functional outcomes described in the literature
| Authors | No. of patients | Site | Type of treatment | Functional outcome | Follow-up | Results |
|---|---|---|---|---|---|---|
| Ackerstaff et al. [ | 207 (88 vs. 92 3 months) | Oral cavity, oropharynx, hypopharynx, larynx | CCRT ia vs. CCRT iv | Tube-feeding | 3 months | 64 (70%) |
| Buchbinder et al. [ | 21 (3 exercise groups; unassisted exercises | Head and neck cancer | Resection and/or reconstruction combined with RT | Mouth opening <30 mm | 2.5 months | Mean 21.6 mm after exercises: TheraBite + 13.6 mm unassisted exercises + 6.0 mm tongue depressors + 4.4 mm |
| Carroll et al. [ | 18 (pretreatment exercises | Oropharynx, hypopharynx, larynx | CCRT | Aspiration PAS score (VMBS) | 3 months | Mean 4.11 vs. 3.88 |
| Eisbruch et al. [ | 20 (post-1) | Oral cavity, nasopharynx, oropharynx, hypopharynx, larynx, other | CCRT | Aspiration (VMBS) | 1–3 months | 13 (65%) |
| Grandi et al. [ | 54 (No exercises | Head and neck (masticatory muscles in the irradiated field) | RT | Mouth opening | Final day of RT | Mean reduction No exercises: 4.94, Group 1: 3.80, Group 2: 1.38 |
| Kotz et al. [ | 12 | Oral cavity, oropharynx, larynx, unknown | CCRT | Aspiration (VMBS) residue | Mean 2 months | 4 (33%) 4 (33%) |
| Lazarus et al. [ | 46 (3 months | Oral cavity, oropharynx | CCRT | Oral intake tube-feeding (VMBS) | 3 months | 4 (18%) intake <50% 4 (18%) |
| Logemann et al. [ | 48 | Nasopharynx, oropharynx, hypopharynx, larynx | CCRT/RT | Oral intake | 3 months | 12 (25%) |
| Logemann et al. [ | 53 | Nasopharynx, oropharynx, hypopharynx, larynx, unknown | CCRT | Tube-feeding oral intake aspiration (VMBS) | 3 months | 21 (40%) 12 (23%) intake <50% 12 (23%) |
| Newman et al. [ | 47 | Oral cavity, oropharynx, hypopharynx, larynx | CCRT | Tube-feeding Weight oral intake | Final day of RT | 12 (26%) Mean loss 10% 37 (79%) not normal |
| Newman et al. [ | 30 (RADPLAT | Oral cavity, pharynx, larynx | RADPLAT vs. CCRT | Aspiration (VMBS) oral intake | 1 months | 7 vs. 27% 57 vs. 50% intake <50% |
| Nguyen et al. [ | 63 | Nasopharynx, oral cavity, oropharynx, hypopharynx, larynx | CCRT | Aspiration (VMVS) tube-feeding | Mean 2 months | 31 (49%) 18 (29%) |
| Oates et al. [ | 14 | Nasopharyngeal cancer | CCRT | Tube-feeding weight | 3 months | 13 (93%) Mean weight loss 8.2 kg (13%) |
RT radiotherapy, CCRT chemoradiotherapy, RADPLAT radiotherapy and cisplatin, VMBS videofluoroscopy modified barium swallow, Qol quality of life